Holen Sie sich die Stockscreener-App
8.955
8.25%
-0.805
Schlusskurs vom Vortag:
$9.76
Offen:
$9.77
24-Stunden-Volumen:
976.03K
Relative Volume:
1.00
Marktkapitalisierung:
$934.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-238.77M
KGV:
-0.334
EPS:
-26.808
Netto-Cashflow:
$-216.62M
1W Leistung:
-18.37%
1M Leistung:
+20.85%
6M Leistung:
+173.02%
1J Leistung:
+8.94%
1-Tages-Spanne:
$8.68
$9.865
1-Wochen-Bereich:
$8.68
$11.17
52-Wochen-Spanne:
$2.7601
$12.44
Alumis Inc Stock (ALMS) Company Profile
Firmenname
Alumis Inc
Sektor
Branche
Telefon
650-231-6625
Adresse
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
8.955 | 1.02B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Fortgesetzt | Guggenheim | Buy |
| 2025-01-30 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Eingeleitet | Guggenheim | Buy |
| 2024-07-23 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-23 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Alumis issues breach notice to Climb Bio over $3 million milestone payment - Investing.com Nigeria
Alumis IncCo & Its Unit Issues Notice Of Material Breach & Notification Of Claim For Indemnification To Climb BioSEC Filing - TradingView — Track All Markets
Alumis issues breach notice to Climb Bio over $3 million milestone payment By Investing.com - Investing.com South Africa
Alumis Faces Legal Dispute Over Unpaid Budoprutug Milestone - TipRanks
Alumis Inc. Issues Notice of Material Breach to Climb Bio - TradingView — Track All Markets
Climb Bio files complaint against Alumis and AcelyrinSEC filing - marketscreener.com
Climb Bio Challenges Alumis Milestone and Royalty Obligations - TipRanks
Climb Bio, Inc. Files Legal Complaint Over Asset Purchase Agreement - TradingView — Track All Markets
Alumis (NASDAQ:ALMS) Shares Down 3.7%What's Next? - MarketBeat
Trium Capital LLP Buys 474,072 Shares of Alumis Inc. $ALMS - MarketBeat
H.C. Wainwright cuts Alumis stock target to $19, maintains Buy rating - MSN
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
How Investors May Respond To Alumis (ALMS) Joining The S&P Pharmaceuticals Select Industry Index - simplywall.st
Alumis price target raised to $20 from $14 at HC Wainwright - MSN
Alumis Inc.(NasdaqGS: ALMS) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Leerink says Takeda results signal positive readthrough for Alumis - MSN
Assessing Alumis (ALMS) Valuation After S&P Pharma Index Inclusion and Reinforced Analyst Optimism - Sahm
Why Alumis Inc. stock remains on buy listsQuarterly Investment Review & Verified Technical Trade Signals - Улправда
Can Alumis Inc. stock hit analyst price targetsJuly 2025 PreEarnings & Growth Oriented Trade Recommendations - DonanımHaber
How Alumis Inc. stock reacts to job market dataJuly 2025 Price Swings & Daily Price Action Insights - Bölüm Sonu Canavarı
Why Alumis Inc. stock is favored by top institutions2025 Historical Comparison & Expert Verified Movement Alerts - DonanımHaber
How supply chain issues affect Alumis Inc. stockQuarterly Profit Report & Free Community Consensus Stock Picks - Улправда
HC Wainwright & Co. Maintains Alumis (ALMS) Buy Recommendation - Nasdaq
Alumis (NASDAQ:ALMS) Trading 7.4% HigherHere's Why - MarketBeat
Alumis Inc.: Validated TYK2 Class, Multiple 2026 Catalysts, and Discounted Valuation Support Buy Rating - TipRanks
Alumis (ALMS) Receives Updated Price Target and Maintained 'Buy' Rating | ALMS Stock News - GuruFocus
Is Alumis Inc. stock dividend yield sustainableGDP Growth & Long-Term Safe Investment Ideas - Улправда
Alumis price target raised to $20 from $14 at H.C. Wainwright - TipRanks
Published on: 2025-12-18 09:56:13 - moha.gov.vn
Alumis (NASDAQ:ALMS) Stock Price Down 5.4%Time to Sell? - MarketBeat
Alumis Inc. (NASDAQ:ALMS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Price Action: How buybacks impact Alumis Inc stock valueQuarterly Earnings Report & Expert Curated Trade Setup Alerts - moha.gov.vn
General Atlantic L.P. Makes New Investment in Alumis Inc. $ALMS - MarketBeat
Alumis (NASDAQ:ALMS) Stock Price Down 5.2%Here's Why - MarketBeat
Insider Stock Purchases: December 10, 2025 - Quiver Quantitative
Velan Capital Investment Management LP Takes Position in Alumis Inc. $ALMS - MarketBeat
Alumis Insider Bought Shares Worth $1,833,760, According to a Recent SEC Filing - marketscreener.com
Alumis Inc (ALMS) director Akkaraju buys shares worth $1.83 million - Investing.com
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 186,377 Shares of Stock - MarketBeat
Alumis Inc (ALMS) director Akkaraju buys shares worth $1.83 million By Investing.com - Investing.com Australia
Alumis stock hits 52-week high at 11.3 USD By Investing.com - Investing.com Canada
Alumis stock hits 52-week high at 11.3 USD - Investing.com India
Assessing Alumis (ALMS) Valuation After Director Srinivas Akkaraju’s $2 Million Insider Share Purchase - simplywall.st
Can Alumis Stock Hold Up When Markets Turn? - Trefis
What Do Director Insider Buys Reveal About Alumis’ (ALMS) Long-Term Alignment With Shareholders? - simplywall.st
Alumis (NASDAQ:ALMS) Trading Up 11.8% Following Insider Buying Activity - MarketBeat
Aug PreEarnings: Can Alumis Inc stock continue upward trendJuly 2025 Price Swings & AI Powered Market Entry Strategies - moha.gov.vn
Alumis (NASDAQ:ALMS) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Alumis (NASDAQ:ALMS) Rating Increased to Hold at Wall Street Zen - MarketBeat
Finanzdaten der Alumis Inc-Aktie (ALMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alumis Inc-Aktie (ALMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director |
Dec 03 '25 |
Buy |
7.75 |
100,000 |
775,000 |
1,012,849 |
| AKKARAJU SRINIVAS | Director |
Dec 02 '25 |
Buy |
7.55 |
96,000 |
724,800 |
912,849 |
| AKKARAJU SRINIVAS | Director |
Dec 04 '25 |
Buy |
8.18 |
66,027 |
540,101 |
1,078,876 |
| AKKARAJU SRINIVAS | Director |
Dec 01 '25 |
Buy |
7.46 |
86,350 |
644,171 |
816,849 |
| AKKARAJU SRINIVAS | Director |
Nov 26 '25 |
Buy |
7.64 |
48,537 |
370,823 |
691,797 |
| AKKARAJU SRINIVAS | Director |
Nov 28 '25 |
Buy |
7.64 |
38,702 |
295,683 |
730,499 |
| Foresite Capital Management VI | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Tananbaum James B. | Director |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Foresite Labs, LLC | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| AKKARAJU SRINIVAS | Director |
Nov 20 '25 |
Buy |
7.20 |
125,743 |
905,350 |
643,260 |
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):